EFFICACY AND SAFETY OF NINTEDANIB IN COMBINATION WITH IMMUNOSUPPRESSIVE AGENTS FOR PROGRESSIVE FIBROSING CTD-ILD IN CLINICAL PRACTICE

Authors
Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2023
This article has no abstract
Epistemonikos ID: b9a5ebf08729744d0a8e67d054d043162c8c9eb4
First added on: Feb 16, 2025